MetLife (NYSE:MET) posts better-than-expected sales in Q3 2026
MetLife (MET) reported Q3 2026 revenue of $20.52B, up 14.6% YoY and beating estimates by 3.5%. EPS of $2.78 was in line with expectations. Net premiums missed estimates, and shares remained flat post-earnings. Book value per share grew 35.6% YoY to $59.41, but missed estimates by 0.6%.
How this was made

The 30-second read
Why it matters
The mixed results suggest limited immediate price movement; investors will watch guidance and premium trends for future direction.
Market read
First‑time earnings disclosure for a large‑cap insurer; relevance driven by revenue beat and premium miss.
What to watch
Potential impact of rising interest rates on investment income and upcoming regulatory changes for insurers were not discussed.
Background
MetLife's Q3 2026 earnings were released, showing a revenue beat but mixed operating metrics.
Ticker impact
MetLife reported Q3 2026 revenue of $20.52B, beating estimates by 3.5% while EPS was in line, marking the first public release of these results.
likely modest upward pressure as the market prices in the revenue beat, but limited upside due to in‑line EPS
Large‑cap insurer with a revenue surprise; investors typically react positively to top‑line beats, yet earnings were flat, suggesting a balanced reaction.
Market effects
Insurance sector may see slight re‑rating as revenue growth outpaces peers, but premium miss highlights competitive pressure.
U.S. financials could experience modest gains in pre‑market trading.
Limited; impact confined to U.S. insurers and broader financials.
Counterpoint
Investors might view the premium miss and flat EPS as a sign of underlying weakness, prompting a short bias despite the revenue beat.
Key entities
- CompanyMetLife
Global insurer reporting Q3 2026 results.




